2016
DOI: 10.17264/stmarieng.7.117
|View full text |Cite
|
Sign up to set email alerts
|

MRI-based Annual Cerebellar Volume Atrophy Rate as a Biomarker of Disease Progression in Patients with Cerebellar Degeneration

Abstract: Background: The rate of disease progression differs among patients with degenerative cerebellar ataxia. Purpose: We determined the annual cerebellar volume atrophy rate with magnetic resonance imaging (MRI) and disease progression in ataxia with the International Cooperative Ataxia Rating Scale (ICARS) according to the subtype of cerebellar degeneration using longitudinal follow-up data. Methods: We examined 50 patients consisting of 22 cases of spinocerebellar ataxia (SCA), 17 cases of multiple system atrophy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 34 publications
0
3
0
Order By: Relevance
“…We demonstrated that the cerebellar volume obtained from MRI correlates well with the International Cooperative Ataxia Rating Scale (ICARS) score in a broad spectrum of degenerative cerebellar ataxias [22]. We also confirmed that the annual atrophy rate of the cerebellar volume and the annual progression of the ICARS score were significantly different among subtypes of cerebellar degeneration [23]. However, categorizing individual symptom progression only by the atrophy rate of the cerebellum is not feasible.…”
Section: Introductionmentioning
confidence: 73%
See 2 more Smart Citations
“…We demonstrated that the cerebellar volume obtained from MRI correlates well with the International Cooperative Ataxia Rating Scale (ICARS) score in a broad spectrum of degenerative cerebellar ataxias [22]. We also confirmed that the annual atrophy rate of the cerebellar volume and the annual progression of the ICARS score were significantly different among subtypes of cerebellar degeneration [23]. However, categorizing individual symptom progression only by the atrophy rate of the cerebellum is not feasible.…”
Section: Introductionmentioning
confidence: 73%
“…However, MRI-based cerebellar volume measurements have never been established as a stratification tool to categorize disease progression. Recently, we demonstrated that the annual atrophy rate of the cerebellar volume and the annual progression of the ICARS score are significantly different among subtypes of cerebellar degeneration, but categorizing individual symptom progression only with the atrophy rate of the cerebellum is not feasible [ 22 , 23 ]. Our current study demonstrated that cluster analysis based on the annual atrophy rates of the corpus callosum and cerebellum successfully categorized the difference in disease progression in a broad spectrum of degenerative cerebellar ataxias.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation